Group 1 - Immunocore Holdings PLC (IMCR) shares have increased by 20.2% over the past four weeks, closing at $36.60, with a mean price target of $60.47 indicating a potential upside of 65.2% [1] - The average of 15 short-term price targets ranges from a low of $24 to a high of $100, with a standard deviation of $21.18, suggesting variability in analyst estimates [2] - Analysts show strong agreement on the company's ability to report better earnings than previously predicted, which supports the expectation of an upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 42.9% over the past month, with seven estimates revised higher and no negative revisions [12] - IMCR holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can indicate the direction of price movement, which appears to be a good guide [13]

Core Viewpoint - Kamada (KMDA) shows significant upside potential with a mean price target of $14.17, indicating a 106.9% increase from the current price of $6.85 [1] Price Targets and Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $3.13, suggesting variability among analysts [2] - The lowest estimate of $11 indicates a 60.6% increase, while the highest estimate suggests a 192% surge to $20 [2] - A low standard deviation indicates a high degree of agreement among analysts regarding price movement [9] Analyst Sentiment and Earnings Estimates - Analysts are increasingly optimistic about KMDA's earnings prospects, as reflected in higher EPS estimates [11] - The Zacks Consensus Estimate for the current year has risen by 11% over the past month, with two estimates increasing and no negative revisions [12] - KMDA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Price targets should not be the sole basis for investment decisions, as they can mislead investors [3][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Shares of Candel Therapeutics, Inc. (CADL) have gained 3.2% over the past four weeks to close the last trading session at $5.45, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $21 indicates a potential upside of 285.3%.The average comprises four short-term price targets ranging from a low of $15 to a high of $25, with a standard deviation of $4.90. While the lowest estimate ind ...

Group 1 - Mind Medicine (MindMed) Inc. (MNMD) closed at $7.26, with a 4.8% gain over the past four weeks, and a mean price target of $24.50 suggests a 237.5% upside potential [1] - The mean estimate includes 10 short-term price targets with a standard deviation of $12.13, indicating variability; the lowest estimate of $16 suggests a 120.4% increase, while the highest estimate of $55 indicates a 657.6% potential surge [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases, as the Zacks Consensus Estimate for the current year has increased by 4% over the past month [4][12] Group 2 - MNMD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a solid potential upside [13] - The clustering of price targets with a low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement direction [9] - While price targets are often viewed skeptically, the direction they imply can serve as a useful guide for further research into the stock's potential [10]

Core Viewpoint - Ooma (OOMA) has shown an 8.8% increase in stock price over the past four weeks, with a mean price target of $18.30 indicating a potential upside of 34.1% from the current price of $13.65 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $1.10, where the lowest estimate is $17 (24.5% increase) and the highest is $20 (46.5% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about Ooma's earnings prospects, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] - The Zacks Consensus Estimate for the current year has risen by 6.2% over the past month, with three estimates increasing and no negative revisions [12] Zacks Rank and Investment Potential - Ooma holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement [13]

Group 1 - Broadwind Energy, Inc. (BWEN) shares have declined by 11.7% over the past two weeks, but a hammer chart pattern formed in the last trading session suggests potential support and a possible trend reversal [1] - The hammer pattern indicates a technical signal of nearing a bottom, with reduced selling pressure, and is supported by a strong consensus among Wall Street analysts raising earnings estimates for BWEN [2][7] - The consensus EPS estimate for BWEN has increased by 23.1% over the last 30 days, indicating analysts' agreement on the company's potential for better earnings [8] Group 2 - The Zacks Rank for BWEN is currently 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which typically outperform the market [9] - A Zacks Rank of 2 serves as a strong indicator of a potential trend reversal, as it helps identify when a company's prospects are improving [9]

Group 1 - Pagaya Technologies Ltd. (PGY) closed at $17.13, with a 50.8% gain over the past four weeks, and a mean price target of $22.03 suggests a 28.6% upside potential [1] - The mean estimate consists of nine short-term price targets with a standard deviation of $6.97, indicating variability; the lowest estimate is $13.75 (19.7% decline), while the highest is $36 (110.2% increase) [2] - Analysts show strong agreement on PGY's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for PGY's current year earnings has increased by 84% over the last 30 days, with two estimates moving higher and no negative revisions [12] - PGY holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [13]

Core Viewpoint - Nexxen International Ltd. (NEXN) has seen a 16.4% increase in share price over the past four weeks, closing at $11.72, with a potential upside of 25.2% based on Wall Street analysts' mean price target of $14.67 [1][11]. Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $2.55, indicating variability among analysts; the lowest estimate is $9 (23.2% decline), while the highest is $18 (53.6% increase) [2][9]. - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement direction, which can serve as a starting point for further research [9]. Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about NEXN's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11][12]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 10.8%, with one estimate moving higher and no negative revisions [12]. Zacks Rank and Investment Potential - NEXN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside in the near term [13].

Group 1 - Janus International Group, Inc. (JBI) shares have increased by 18.5% over the past four weeks, closing at $8.25, with a mean price target of $10.90 indicating a potential upside of 32.1% [1] - The mean estimate consists of five short-term price targets with a standard deviation of $2.97, where the lowest estimate is $7.50 (indicating a 9.1% decline) and the highest estimate is $14 (indicating a 69.7% increase) [2] - Analysts have shown strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 35.4% over the last 30 days [11][12] Group 2 - JBI currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - The consensus price target, while not entirely reliable, suggests a positive direction for JBI's stock price movement [13] - Analysts' price targets can often be overly optimistic due to business incentives, which may lead to inflated estimates [8]

Core Viewpoint - Evolv Technologies Holdings, Inc. (EVLV) has shown a significant price increase of 30% over the past four weeks, with a mean price target of $7.06 indicating a potential upside of 29.3% from the current price of $5.46 [1] Price Targets and Analyst Estimates - The mean estimate consists of four short-term price targets with a standard deviation of $1.16, where the lowest estimate is $5.50 (0.7% increase) and the highest is $8.25 (51.1% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Agreement - There is a growing optimism among analysts about EVLV's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 23.3% over the past month, with no negative revisions reported [12] Zacks Rank and Investment Potential - EVLV holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside in the near term [13]